Merck & Co Inc

MIL:1MRKX (USA)  
€ 117.60 (0%) Feb 22
923.29
P/B:
7.95
Market Cap:
€ 302.73B ($ 327.62B)
Enterprise V:
€ 326.84B ($ 353.72B)
Volume:
83.00
Avg Vol (2M):
84.00
Also Trade In:
Volume:
83.00
Avg Vol (2M):
84.00

Business Description

Description
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent pediatric diseases as well as human papillomavirus, or HPV. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the company's sales are generated in the United States.

Financials (Next Earnings Date:2024-04-26 Est.)

MIL:1MRKX's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Merck & Co Inc Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil €) 55,780.267
EPS (TTM) (€) 0.171
Beta 0
Volatility % 0
14-Day RSI 69
14-Day ATR (€) 0.768375
20-Day SMA (€) 115.76
12-1 Month Momentum % 0
52-Week Range (€) 91.8 - 119.2
Shares Outstanding (Mil) 2,534.02

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 4
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Merck & Co Inc Filings

Filing Date Document Date Form
No Filing Data

Merck & Co Inc Stock Events

Financials Calendars
Event Date Price(€)
No Event Data

Merck & Co Inc Frequently Asked Questions

What is Merck & Co Inc(MIL:1MRKX)'s stock price today?
The current price of MIL:1MRKX is €117.60. The 52 week high of MIL:1MRKX is €119.20 and 52 week low is €91.80.
When is next earnings date of Merck & Co Inc(MIL:1MRKX)?
The next earnings date of Merck & Co Inc(MIL:1MRKX) is 2024-04-26 Est..
Does Merck & Co Inc(MIL:1MRKX) pay dividends? If so, how much?
The  Dividend Yield %  of Merck & Co Inc(MIL:1MRKX) is 0.6% (As of Today), Highest Dividend Payout Ratio of Merck & Co Inc(MIL:1MRKX) was 0.84. The lowest was 0.37. And the median was 0.49. The  Forward Dividend Yield % of Merck & Co Inc(MIL:1MRKX) is 2.41%. For more information regarding to dividend, please check our Dividend Page.

Press Release

Subject Date
No Press Release